Literature DB >> 17123230

In utero stem cell transplantation.

Magnus Westgren1.   

Abstract

Successful in utero stem cell transplantations with hematopoietic or other stem cells should represent a major step forward in the management of patients with congenital, hematological, metabolic, and immunological disorders. The possibility of performing cell transplantations with stem cells across histoincompatibility barriers without chemotherapy has great potential for both pre and postnatal transplantations. The present article includes an overview of this topic with special reference to different animal models and the experience in humans in regard to fetal stem cell transplantations. This area of research holds great promise for the future, and development of efficient intrauterine stem cell treatment may enable the relative new speciality of fetal medicine to progress from a mainly diagnostic to a therapeutic medical subject.

Entities:  

Mesh:

Year:  2006        PMID: 17123230     DOI: 10.1055/s-2006-952156

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  8 in total

1.  Engraftment potential of adipose tissue-derived human mesenchymal stem cells after transplantation in the fetal rabbit.

Authors:  Itziar Martínez-González; Rafael Moreno; Jordi Petriz; Eduard Gratacós; Josep M Aran
Journal:  Stem Cells Dev       Date:  2012-07-31       Impact factor: 3.272

2.  Regulation of the earliest immune response to in utero hematopoietic cellular transplantation.

Authors:  Amir M Alhajjat; Emily T Durkin; Aimen F Shaaban
Journal:  Chimerism       Date:  2010-10

3.  Donor major histocompatibility complex class I expression determines the outcome of prenatal transplantation.

Authors:  Emily T Durkin; Kelly A Jones; Dina Elnaggar; Aimen F Shaaban
Journal:  J Pediatr Surg       Date:  2008-06       Impact factor: 2.545

4.  Mechanistic Insights into Factor VIII Immune Tolerance Induction via Prenatal Cell Therapy in Hemophilia A.

Authors:  Martin Rodriguez; Christopher D Porada; Graҫa Almeida-Porada
Journal:  Curr Stem Cell Rep       Date:  2019-11-20

5.  Transplantation tolerance induced in humans at the fetal or the neonatal stage.

Authors:  Jean-Louis Touraine; Kamel Sanhadji
Journal:  J Transplant       Date:  2011-08-18

Review 6.  NK cell tolerance as the final endorsement of prenatal tolerance after in utero hematopoietic cellular transplantation.

Authors:  Amir M Alhajjat; Amanda E Lee; Beverly S Strong; Aimen F Shaaban
Journal:  Front Pharmacol       Date:  2015-03-18       Impact factor: 5.810

7.  In utero therapy for congenital disorders using amniotic fluid stem cells.

Authors:  Durrgah L Ramachandra; Steven S W Shaw; Panicos Shangaris; Stavros Loukogeorgakis; Pascale V Guillot; Paolo De Coppi; Anna L David
Journal:  Front Pharmacol       Date:  2014-12-19       Impact factor: 5.810

Review 8.  Experimental and clinical progress of in utero hematopoietic cell transplantation therapy for congenital disorders.

Authors:  Chunyu Shi; Lu Pan; Zheng Hu
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.